Crypto Jurisdictions: Global Regulatory Convergence
As regulatory frameworks across the U.S., Europe, Asia, and the Gulf mature and converge in their treatment of digital assets, […]
New Hope Corporation (ASX:NHC) Delivers FY26 Operational Performance Above Guidance Across Key Mines
Highlights New Hope Corporation (ASX:NHC) reported FY26 production and sales above its guided ranges. Group saleable coal
MSTR Stock On Track To Lead Weekly Gains Among Crypto Equities – Bitcoin Rally Puts $1.36B Back On Strategy’s Books — TradingView News
Michael Saylor’s Strategy (MSTR) extended gains in pre-market trade Friday, leading a rally among large-cap crypto-linked stocks after Bitcoin’s (BTC)
Drops Below IPO Price Again, May Pull Back Toward $100 in the Short Term
TradingKey – As of the US market close on August 20 Eastern Time, SpaceX (SPCX) shares weakened again, falling 4.05%
Nomura’s Laser Digital receives Japanese crypto exchange license – Ledger Insights
Nomura’s digital asset subsidiary Laser Digital has completed its registration as a crypto asset exchange service provider in Japan under
Woodside Energy (ASX:WDS) Approaches Half-Year Results With Scarborough LNG Milestone Ahead
Highlights Woodside Energy (ASX:WDS) is approaching its FY26 half-year results scheduled for 25 August 2026. Second-quarter Revenue increased
Crypto Surge Comes Even as Trading Volumes Crater — Market Talk
This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment
COIN Price Breaks Above $180, Poised to Rise Over 20% Further
TradingKey – Coinbase briefly broke above $180, with potential for a further 22% gain if it holds that level. On
Ripple, Bitcoin & Crypto – European Wrap 21 August
Ripple (XRP) edges higher on Friday to trade above $1.40 as bulls aim for a continuation of the rally above
Paradigm Biopharmaceuticals (ASX:PAR) Awaits Key Zilosul Phase 3 Data Milestones
Highlights Paradigm Biopharmaceuticals (ASX:PAR) continues advancing its Phase 3 osteoarthritis trial for Zilosul. The company completed enrolment of